Kiran Relekar is an expert in the field of Internal Medicine. He went to New York Medical College. Doctor Kiran V. Relekar, MD is also a published doctor. He has 2 paper published. The most recent paper is: A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma. He accepts all Medicare patients.
|
Dr. Jennifer R. White, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott A. Holliday, MD
|
|
Dr. Lisa Z. Mewhort, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sanath K. Allampati, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jennifer E. Thomas, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lyle T. Olson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sarah L. Lim, DO
|
|
Dr. Rustum A. Shahzad, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jessica L. Barrett, DO
|
|
Dr. Christopher L. Schumann, MD
|
|
Dr. Chirag R. Patel, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adam G. Manko, MD
This Doctor is OpenDoctor Recommended.
|